TTBT01
Phase 2- Indications
- Persistent corneal epithelial defect, Dry eye disease
Company intelligence / Profile preview
Ocular Clinical Research (Ocular CRC) provides specialized consulting services in ophthalmology clinical research and drug safety. The firm offers executive leadership support, medical monitoring for trials, training and placement of medical professionals into biopharmaceutical companies developing therapies for eye diseases. Their expertise spans all major subfields within ophthalmic drug development and they are recognized for building high-quality teams to lead and monitor clinical trials globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ocular Clinical Research.